Areas of white matter hyperintensities and motor symptoms of Parkinson disease
- PMID: 32576636
- DOI: 10.1212/WNL.0000000000009890
Areas of white matter hyperintensities and motor symptoms of Parkinson disease
Abstract
Objective: To determine whether deep white matter and periventricular hyperintensities affect the motor symptoms of Parkinson disease (PD) differently, we analyzed MRI and dopamine transporter imaging.
Methods: We analyzed the medical records of patients with de novo PD who underwent dopamine transporter PET scanning and MRI at their first visit. Deep white matter and periventricular hyperintensities were scored with a visual rating scale, and motor symptoms were assessed by Unified Parkinson's Disease Rating Scale motor score and tremor, rigidity, bradykinesia, and axial symptom subscores. The influence of white matter hyperintensity on motor symptoms was explored using multivariable linear regression models.
Results: A total of 93 patients (mean age, 67.2 ± 9.9 years; 44 male) were included and the mean motor score was 25.0 ± 10.8. Subscores for bradykinesia and axial symptoms were correlated with both deep white matter and periventricular hyperintensities scores. Multivariable linear regression models revealed that deep white matter hyperintensities score was significantly associated with subscore for bradykinesia and periventricular hyperintensities score was associated with subscores for bradykinesia and axial symptoms after adjusting for putaminal dopamine transporter availability and clinical factors.
Conclusions: These results demonstrate that deep white matter hyperintensities are associated with bradykinesia and periventricular hyperintensities are associated with bradykinesia and axial symptoms in patients with PD independently of the severity of dopaminergic depletion.
© 2020 American Academy of Neurology.
Similar articles
-
White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.Mov Disord. 2021 Jun;36(6):1411-1419. doi: 10.1002/mds.28510. Epub 2021 Jan 29. Mov Disord. 2021. PMID: 33513293
-
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.Brain. 2011 Aug;134(Pt 8):2358-65. doi: 10.1093/brain/awr139. Epub 2011 Jun 8. Brain. 2011. PMID: 21653540 Free PMC article.
-
Association between white matter lesions and Parkinson's disease: an impact on Postural/Gait difficulty phenotype and cognitive performance.Neurol Res. 2022 Dec;44(12):1122-1131. doi: 10.1080/01616412.2022.2112378. Epub 2022 Aug 22. Neurol Res. 2022. PMID: 35994524
-
The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.J Neural Transm (Vienna). 2016 Mar;123(3):241-50. doi: 10.1007/s00702-015-1470-9. Epub 2015 Oct 19. J Neural Transm (Vienna). 2016. PMID: 26483133 Review.
-
PET studies in Parkinson's disease motor and cognitive dysfunction.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S96-9. doi: 10.1016/S1353-8020(11)70031-1. Parkinsonism Relat Disord. 2012. PMID: 22166468 Review.
Cited by
-
The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.Ann Clin Transl Neurol. 2021 Sep;8(9):1917-1934. doi: 10.1002/acn3.51429. Epub 2021 Jul 26. Ann Clin Transl Neurol. 2021. PMID: 34310081 Free PMC article. Review.
-
A deep semantic segmentation correction network for multi-model tiny lesion areas detection.BMC Med Inform Decis Mak. 2021 Jul 30;21(Suppl 2):89. doi: 10.1186/s12911-021-01430-z. BMC Med Inform Decis Mak. 2021. PMID: 34330249 Free PMC article.
-
Regional white matter hyperintensity volume in Parkinson's disease and associations with the motor signs.Ann Clin Transl Neurol. 2023 Sep;10(9):1502-1512. doi: 10.1002/acn3.51839. Epub 2023 Jun 24. Ann Clin Transl Neurol. 2023. PMID: 37353980 Free PMC article.
-
Parkinson's disease cerebrovascular reactivity pattern: A feasibility study.J Cereb Blood Flow Metab. 2024 Oct;44(10):1774-1786. doi: 10.1177/0271678X241241895. Epub 2024 Apr 5. J Cereb Blood Flow Metab. 2024. PMID: 38578669 Free PMC article.
-
Nicotinamide Improves Cognitive Function in Mice With Chronic Cerebral Hypoperfusion.Front Neurol. 2021 Jan 25;12:596641. doi: 10.3389/fneur.2021.596641. eCollection 2021. Front Neurol. 2021. PMID: 33569040 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical